Skip to main content

Table 2 Preoperative and postoperative (6 weeks) range of motion (ROM) and patientreported outcome measures (PROM) in non-TXA and TXA groups

From: Tranexamic acid is associated with selective increase in inflammatory markers following total knee arthroplasty (TKA): a pilot study

 

Non-TXA

TXA

p value

Preoperative:

 ROM

  Flexion (°)

115 ± 5

121 ± 5

0.411

  Extension (°)

5 ± 1

2 ± 1

0.046*

 KOOS Total

46 ± 6

41 ± 4

0.470

 KOOS Pain

10 ± 2

8 ± 1

0.417

 KOOS Function

32 ± 4

29 ± 3

0.457

 KOOS Movement

4 ± 0.7

4 ± 0.4

1.000

 OKS

22 ± 3

29 ± 3

0.457

 EQ5D 3L VAS

64 ± 7

67 ± 4

0.760

Postoperative 6 weeks:

 ROM

  Flexion (°)

104 ± 5

110 ± 4§

0.297

  Extension (°)

7 ± 1

4 ± 1

0.134

 KOOS Total

26 ± 4§

17 ± 3§

0.096

 KOOS Pain

5 ± 1§

4 ± 1§

0.304

 KOOS Function

18 ± 3§

11 ± 2§

0.098

 KOOS Movement

3 ± 0.5

2 ± 0.3§

0.063

 OKS

27 ± 2

32 ± 2

0.097

 EQ5D 3L VAS

67 ± 7

75 ± 4

0.339

 FJS

62 ± 4

52 ± 6

0.170

  1. Data represents mean ± SEM
  2. KOOS The Knee Injury and Osteoarthritis Outcomes Score, OKS Oxford Knee Score, EQ5D (3L) EuroQol 5-Dimension 3-Level Assessment, FJS Forgotten Joint Score. p < 0.05 between non-TXA and TXA group; §p < 0.05 compared with preoperative value